Recent News

• 11.13.2025 - ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025
• 11.06.2025 - ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025
• 11.04.2025 - ImmuCell Announces Onboarding of New CEO and Related Management Changes
• 10.07.2025 - ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 of 2025
• 09.29.2025 - ImmuCell Announces Selection of its Next President and CEO
• 08.14.2025 - ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2025
• 08.12.2025 - ImmuCell Announces Bank Debt Refinancing

Recent Filings

• 11.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.07.2025 - 3 Initial statement of beneficial ownership of securities
• 11.04.2025 - EX-99.1 EX-99.1
• 11.04.2025 - 8-K Current report
• 10.07.2025 - 8-K Current report
• 10.07.2025 - EX-99.1 EX-99.1
• 09.30.2025 - 8-K Current report
• 09.30.2025 - EX-99.1 EX-99.1
• 08.25.2025 - 8-K Current report
• 08.14.2025 - EX-99.1 EX-99.1